收集神经科医生和患者的反,以指导开发帕金森病应用程序 (DigiPark):定性,非干预性研究
Martin Duracinsky1,2, Eva Brown Hajdukova1, Fabienne Péretz3,4
1Patient-Reported Outcomes Research, Health Economics Clinical Trial Unit, Hotel-Dieu Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.
JMIR human factors
|December 31, 2024
概括
这项研究探讨了对帕金森病 (PD) 智能手机应用程序的需求. 患者和神经科医生的反强调了用户友好的设计和进度跟踪,以更好地管理PD.
科学领域:
- 神经学 神经学
- 数字健康数字健康
- 人与计算机的交互
背景情况:
- 帕金森病 (PD) 是一种进展性神经退行性疾病,具有多种运动和非运动症状.
- 智能手机为提高PD症状的监测和管理提供了一个有希望的途径.
研究的目的:
- 为了研究神经病学家和患者的设计和功能偏好,开发了一个新的智能手机应用程序DigiPark,旨在管理帕金森病.
- 收集有关用户对帕金森病患者中心数字健康工具需求的见解.
主要方法:
- 采用了定性,非干预性研究设计.
- 数据收集涉及与9位专门从事PD的神经病学家进行半结构化采访.
- 实验室对5名被诊断患有帕金森病的患者进行了可用性测试.
主要成果:
- 神经学家强调,需要一个以患者为中心的应用程序,具有个性化的功能,以提高生活质量和患者-提供者沟通.
- 患者更喜欢简单的用户界面和对应用程序好处的明确阐述,对时间承诺和功能复杂性表示担忧.
- 患者对随着时间的推移跟踪和监测病情的功能表现出显著的兴趣,这表明需要明确的价值主张来确保参与.
结论:
- 神经科医生和患者的反为优化DigiPark应用程序的设计和功能提供了补充的见解.
- 合作开发对于将应用与帕金森病管理的实际需求保持一致至关重要.
- 建议通过临床试验进一步验证,以确定DigiPark应用程序的有效性.
相关概念视频
Parkinson's Disease: Treatment
216
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
216
Parkinson's Disease: Overview
476
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
476


